Atlas Trials

Itraconazole as a Targeted Therapy for Inhibiting Hedgehog Pathway Signaling in Esophageal Cancer Patients

Clinical trial NCT02749513 · UNKNOWN

Trial details

NCT number
NCT02749513
Sponsor
Dallas VA Medical Center
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Esophageal Cancer
Start date
2016-01-01
Primary completion
2019-09-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.